Clinical trial
Chemotherapy Followed by Surgery in Treating Women With Stage II or Stage III…
NCT00003953 · Case Comprehensive Cancer Center, Other · Completed
Key facts
| NCT number | NCT00003953 |
|---|---|
| Title | Chemotherapy Followed by Surgery in Treating Women With Stage II or Stage III Breast Cancer |
| Official title | A Phase II Study of Preoperative Dose-Dense Chemotherapy With Sequential Doxorubicin and Docetaxel for Initial Treatment of Operable and Inoperable Stage II-IIIB Breast Cancer |
| Lead sponsor | Case Comprehensive Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Biological, Drug, Procedure, Radiation |
| Interventions | filgrastim, CMF regimen, docetaxel, doxorubicin hydrochloride, tamoxifen citrate, autologous bone marrow transplantation, surgical procedure, radiation therapy |
| Enrollment | 39 |
| Start date | Feb 1, 1999 |
| Primary completion | Nov 1, 2001 |
| Completion | Jan 1, 2013 |
| First posted | Apr 28, 2004 |
| Last update posted | Jan 28, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: